Vericiguat, Vericiguat, Vericiguat, Vericiguat
MK-1242-043
Phase 3 small_molecule active
Quick answer
Vericiguat, Vericiguat, Vericiguat, Vericiguat for Heart Failure due to Systemic Left Ventricular Systolic Dysfunction is a Phase 3 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Heart Failure due to Systemic Left Ventricular Systolic Dysfunction
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active